22 Results for "

phospho-Erk

" in MedChemExpress (MCE) Product Catalog:
Products (22)

22 Results for "phospho-Erk" in MCE Product Catalog:

13
13 Publications Verification
Cat. No.: HY-100609
CAS No.: 134865-74-0
Purity:  99.90%
Target:  

Melatonin Receptor

Research Areas:  

Neurological Disease

4-P-PDOT is a potent, selective and affinity Melatonin receptor (MT2) antagonist. 4-P-PDOT is >300-fold more selective for MT2 than MT1. 4-P-PDOT significantly counteracts Melatonin-mediated antioxidant effects (GSH/GSSG ratio, phospho-ERK, Nrf2 nuclear translocation, Nrf2 DNA-binding activity) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P3419
CAS No.: 929905-12-4
PAMP-12 (unmodified) is an endogenous peptide and is a MrgX2 agonist. PAMP-12 (unmodified) can reduce cAMP accumulation, increase Ca 2+ levels, enhance beta-arrestin recruitment, decrease IP-1, and increases phosphoERK. PAMP-12 (unmodified) can elicit hypotension through inhibiting catecholamine secretion from sympathetic nerve endings and adrenal chromaffin cells. PAMP-12 (unmodified) can be used for the research of hypotension and ulcerative colitis .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P80814
Synonyms: MAPK1/MAPK3

Host:  

Rabbit

Application:  

WB

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80815
Synonyms: MAPK1/MAPK3

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80813
Synonyms: MAPK1/MAPK3

Host:  

Rabbit

Application:  

WB, IP

Reactivity:  

Human, Hamster, Rat

loading...
    loading...
Cat. No.: HY-153738
CAS No.: 2169302-75-2
Purity:  95.91%
Target:  

ERK

Research Areas:  

Cancer

ERK1/2 inhibitor 9 (Probe 1) is a covalent ERK1/2 inhibitor. ERK1/2 inhibitor 9 shows sub-micromolar activity in cells (A375 GI50=0.47 μM). ERK1/2 inhibitor 9 causes the downregulation of phospho-ERK1/2. ERK1/2 inhibitor 9 tagged trans-cyclo-octene (TCO) and Tz-Thalidomide (tetrazine tagged Thalidomide) can form the corresponding ERK-CLIPTAC to elicit degradation of ERK1/2 .
loading...
    loading...
Cat. No.: HY-134654
CAS No.: 2490716-96-4
Purity:  99.60%
Target:  

Ras

Research Areas:  

Cancer

MRTX849 analog 24 is a KRAS G12C inhibitor with a human IC50 of 140 nM. MRTX849 analog 24 binds to KRAS G12C, forms a covalent interaction, and acts as a click probe to bait the protein target in proteomic studies. MRTX849 analog 24 exhibits cellular activity in cancer cells. MRTX849 analog 24 can be used for the research of kras G12C-mutant cancer .
loading...
    loading...
Cat. No.: HY-152168
CAS No.: 77111-29-6
Target:  

PERK Phosphatase

Research Areas:  

Cancer

NSC 295642 is a phosphatase inhibitor. NSC 295642 can significantly increase phospho-Erk cytonuclear differences in intact cells. NSC 295642 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-156549
CAS No.: 2300967-40-0
Target:  

ERK Ras

Research Areas:  

Cancer

KRAS G12C inhibitor 61 (Example 3) inhibits phospho-ERK 1/2 in MIA PaCa-2 cells with an IC50 value of 9 nM. KRAS G12C inhibitor 61 can be used for research of pancreatic, colorectal, and lung cancers .
loading...
    loading...
Cat. No.: HY-100609R
CAS No.: 134865-74-0
4-P-PDOT (Standard) is the analytical standard of 4-P-PDOT. This product is intended for research and analytical applications. 4-P-PDOT is a potent, selective and affinity Melatonin receptor (MT2) antagonist. 4-P-PDOT is >300-fold more selective for MT2 than MT1. 4-P-PDOT significantly counteracts Melatonin-mediated antioxidant effects (GSH/GSSG ratio, phospho-ERK, Nrf2 nuclear translocation, Nrf2 DNA-binding activity) .
loading...
    loading...
Cat. No.: HY-178812
CAS No.: 2098649-83-1
Target:  

PI3K PAK mTOR PERK Apoptosis

Research Areas:  

Cancer

PI3Kα-IN-27 (Compound 50b) is an orally active PI3K-α inhibitor, with an IC50 of 40 nM. PI3Kα-IN-27 effectively inhibits PAK3, p110α, phospho-mTOR and phospho-ERK1/2. PI3Kα-IN-27 induces early Apoptosis. PI3Kα-IN-27 shows anticancer activity against pancreatic cancer, lung cancer, breast cancer .
loading...
    loading...
Cat. No.: HY-P86068
Synonyms: MAPK1/MAPK3

Host:  

Mouse

Application:  

IHC-P, ICC/IF

Reactivity:  

Human, Rat, Mouse

loading...
    loading...
Cat. No.: HY-P3419A
PAMP-12 (unmodified) TFA is an endogenous peptide and is a MrgX2 agonist. PAMP-12 (unmodified) TFA can reduce cAMP accumulation, increase Ca 2+ levels, enhance beta-arrestin recruitment, decrease IP-1, and increases phosphoERK. PAMP-12 (unmodified) TFA can elicit hypotension through inhibiting catecholamine secretion from sympathetic nerve endings and adrenal chromaffin cells. PAMP-12 (unmodified) TFA can be used for the research of hypotension and ulcerative colitis .
loading...
    loading...
Cat. No.: HY-P11467
Gy-CATH is an anionic antimicrobial peptide. Gy-CATH activates MAPK and NF-κB signaling pathways (elevated levels of phospho-ERK, -p38, -JNK, -p65, and -IκBα). Gy-CATH upregulates the expression levels of three physiological anticoagulant pathways. Gy-CATH inhibits ADP-, Collagen-, and PMA-induced platelet aggregation. Gy-CATH has no direct antimicrobial activity, but shows significant preventive abilities against mice infected with Staphylococcus aureus, Escherichia coli, and Methicillin (HY-121544)-resistant Staphylococcus aureus. Gy-CATH exhibits potent immunomodulatory activity, enhancing macrophage-and neutrophil-mediated bactericidal functions. Gy-CATH significantly reduces the extent of pulmonary fibrin deposition and prevents thrombosis in mice .
loading...
    loading...
Cat. No.: HY-P86225
Synonyms: MAPK3; Erk1; PRKM3; Mitogen-activated protein kinase 3; MAP kinase 3; MAPK 3; ERT2; Extracellular signal-regulated kinase 1; Erk-1; Insulin-stimulated MAP2 kinase; MAP kinase isoform p44; p44-MAPK; Microtubule-associated protein 2 kinase; p

Host:  

Rabbit

Application:  

WB, ICC/IF, IP, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P80813A
Synonyms: MAPK1/MAPK3

Host:  

Rabbit

Application:  

WB, IP

Reactivity:  

Human, Hamster, Rat

loading...
    loading...
Cat. No.: HY-P810604
Synonyms: Erk1; PRKM3; P44Erk1; P44MAPK; HS44KDAP; HUMKER1A; MGC20180

Host:  

Rabbit

Application:  

WB, ICC/IF, IHC-P, FC, IF-Tissue

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P85629
Synonyms: Erk 1; Erk 2; Erk-2; Erk1; Erk1/2; Erk2; ERT1; ERT2; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 1

Host:  

Mouse

Application:  

WB

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-184892
CAS No.: 2953305-55-8
Target:  

Ras Raf PERK p38 MAPK Apoptosis

Research Areas:  

Cancer

RMC-8839 is an orally active selective RAS (ON) G13C inhibitor with a Ki value of 28.3 nM. RMC-8839 disrupts the interaction between KRAS G13C and RAF1 (RBD). RMC-8839 inhibits RAS-MAPK pathway signaling by reducing DUSP6 mRNA levels and pERK levels. RMC-8839 induces cytotoxicity, apoptosis (apoptosis) and antiproliferative effects in KRAS G13C-mutated cells. RMC-8839 induces tumor stasis or regression in mice. RMC-8839 can be used in research related to non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-P81156
Synonyms: Erk1 + Erk2 (phospho Thr183/Tyr185); phospho-Erk1/MAPK-1/2(Thr183/Tyr185); Erk 1; Erk 2; Erk-2; Erk1; Erk2; ERT1; ERT2; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 2; Extracellular signal regulated kinase 2; Extracellular signal-regulated kinase 2; HS44KDAP; HUMKER1A; Insulin stimulated MAP2 kinase; MAP kinase 1; MAP kinase 2; MAP kinase isoform p42;

Host:  

Rabbit

Application:  

WB, ELISA, IHC-P, IHC-F, ICC/IF

Reactivity:  

Human, Mouse

loading...
    loading...